| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52688-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52705-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-65284SS | |||
| Azide and BSA Free | NBP2-80625 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-59503SS | |||
| Azide and BSA Free | NBP2-80971 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-27214 | |||
| BSA Free | NBP1-70343SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-24767SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47755-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-2181SS | |||
| Azide and BSA Free | NBP2-80646 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-44853 | |||
| Azide and BSA Free | NBP2-34527-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-48440 | |||
| Azide and BSA Free | NBP3-11434 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-25259 | |||
| Azide and BSA Free | NBP2-25259SS | |||
![Flow Cytometry: CD19 Antibody (FMC63) - Chimeric [NBP2-52688] - Flow-cytometry using anti-CD19 antibody FMC63. Human lymphocytes were stained with an isotype control (NBP2-52638, panel A) or the rabbit-chimeric version of FMC63 (NBP2-52688, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/CD19-Antibody-FMC63-Chimeric-Flow-Cytometry-NBP2-52688-img0001.jpg "Flow Cytometry: CD19 Antibody (FMC63) - Chimeric [NBP2-52688] - Flow-cytometry using anti-CD19 antibody FMC63. Human lymphocytes were stained with an isotype control (NBP2-52638, panel A) or the rabbit-chimeric version of FMC63 (NBP2-52688, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.")
![Flow Cytometry: CD11b Antibody (OX-42) [NB100-65284] - Detection of CD11b in Rat Splenocytes by Flow Cytometry. Rat splenocytes were stained with Mouse Anti-Rat CD11b Monoclonal Antibody (OX-42) [NB100-65284, filled histogram] or Mouse IgG2A Isotype Control Antibody [MAB003, open histogram] followed by anti-Mouse IgG PE-conjugated secondary antibody [F0102B] and Mouse Anti-Rat CD161 Alexa Fluor 647-conjugated Monoclonal Antibody [FAB9766R]. Splenocytes were gated on CD161+ cells.](http://images.novusbio.com/fullsize/CD11b-Antibody-OX-42-Flow-Cytometry-NB100-65284-img0001.jpg "Flow Cytometry: CD11b Antibody (OX-42) [NB100-65284] - Detection of CD11b in Rat Splenocytes by Flow Cytometry. Rat splenocytes were stained with Mouse Anti-Rat CD11b Monoclonal Antibody (OX-42) [NB100-65284, filled histogram] or Mouse IgG2A Isotype Control Antibody [MAB003, open histogram] followed by anti-Mouse IgG PE-conjugated secondary antibody [F0102B] and Mouse Anti-Rat CD161 Alexa Fluor 647-conjugated Monoclonal Antibody [FAB9766R]. Splenocytes were gated on CD161+ cells.")
![Flow Cytometry: CD11b Antibody (OX-42) [NB100-65284] - Detection of CD11b in Rat Bone Marrow cells by Flow Cytometry. Rat cells were stained with Mouse Anti-Rat CD11b Monoclonal Antibody (OX-42) [NB100-65284, filled histogram] or Mouse IgG2A Isotype Control Antibody [MAB003, open histogram] followed by anti-Mouse IgG APC-conjugated secondary antibody [F0101B] .](http://images.novusbio.com/fullsize/antibody/nb100-65284_mouse-monoclonal-cd11b-antibody-ox-42-flow-cell-surface--31102023115850..jpg)
![Simple Western: Survivin Antibody (1277A) [NBP2-59503] - Lane view shows lysates of Jurkat human acute T cell leukemia cell line and HeLa human cervical epithelial carcinoma cell line, loaded at 0.2 mg/mL. A specific band was detected for Survivin at approximately 23 kDa (as indicated) using 10 ug/mL of Rabbit Anti-Human Monoclonal Survivin Antibody [NBP2-59503]. This experiment was conducted under reducing conditions and using the 2-40 kDa separation system.](http://images.novusbio.com/fullsize/Survivin-Antibody-1277A-Simple-Western-NBP2-59503-img0002.jpg "Simple Western: Survivin Antibody (1277A) [NBP2-59503] - Lane view shows lysates of Jurkat human acute T cell leukemia cell line and HeLa human cervical epithelial carcinoma cell line, loaded at 0.2 mg/mL. A specific band was detected for Survivin at approximately 23 kDa (as indicated) using 10 ug/mL of Rabbit Anti-Human Monoclonal Survivin Antibody [NBP2-59503]. This experiment was conducted under reducing conditions and using the 2-40 kDa separation system.")
![Immunohistochemistry-Paraffin: Survivin Antibody (1277A) [NBP2-59503] - Analysis of a formalin-fixed paraffin-embedded (FFPE) human prostate cancer tissue with rabbit monoclonal Survivin Antibody [NBP2-59503] at 2 ug/ml concentration. The staining was developed with HRP-DAB detection method and the sections were counterstained using hematoxylin. This Survivin antibody generated an expected nuclear cytoplasmic immunostaining in a subset of cancer cells, which are potentially the proliferating cells.](http://images.novusbio.com/fullsize/Survivin-Antibody-1277A-Immunohistochemistry-Paraffin-NBP2-59503-img0006.jpg)
![Immunocytochemistry/Immunofluorescence: Survivin Antibody (1277A) [NBP2-59503] - HeLa cells were fixed for 10 minutes using 10% formalin and then permeabilized for 5 minutes using 1X TBS + 0.5% Triton X-100. The cells were incubated with Survivin Antibody (1277A) [NBP2-59503] at 2 ug/ml overnight at 4C and detected with an anti-rabbit DyLight 488 (Green) at a 1:500 dilution. Alpha tubulin (DM1A) [NB100-690] was used as a co-stain at a 1:1000 dilution and detected with an anti-mouse DyLight 550 (Red) at a 1:500 dilution. Nuclei were counterstained with DAPI (Blue). Cells were imaged using a 40X objective.](http://images.novusbio.com/fullsize/Survivin-Antibody-1277A-Immunocytochemistry-Immunofluorescence-NBP2-59503-img0005.jpg)
![Western Blot: Survivin Antibody (1277A) [NBP2-59503] - Total protein from human HeLa and A431 cell lines was separated on a 4-20% gel by SDS-PAGE, transferred to 0.2 um Polyvinylidene fluoride (PVDF) membrane and blocked in 5% non-fat milk in TBST. The membrane was probed with 1.0 ug/ml [NBP2-59503] in block buffer and detected with an anti-rabbit HRP secondary antibody using chemiluminescence. Note: predicted molecular weight is 16 kDa.](http://images.novusbio.com/fullsize/Survivin-Antibody-1277A-Western-Blot-NBP2-59503-img0004.jpg)
![Flow (Intracellular): Survivin Antibody (1277A) [NBP2-59503] - An intracellular stain was performed on HeLa Cells with Survivin Antibody (1277A) [NBP2-59503] (blue) and a matched isotype control [MAB1050] (orange). Cells were fixed with 4% paraformaldehyde, following fixation, cells were permeabilized with 0.1% saponin. Cells were incubated in an antibody dilution of 2.5 ug/mL for 30 minutes at room temperature, followed by rabbit IgG APC-conjugated secondary antibody [F0111, R&D Systems].](http://images.novusbio.com/fullsize/Survivin-Antibody-1277A-Flow-Intracellular-NBP2-59503-img0003.jpg)
![Flow Cytometry: TLR10 Antibody (3C10C5) [NBP1-70343] - Analysis using the Alexa Fluor (R) 647 conjugate of NBP2-27214. Detection of TLR10 on human PBMC using 10 ul (1 ug) of TLR10 antibody and 1 ug of CD19 antibody. Image using the Azide Free format of this antibody.](http://images.novusbio.com/fullsize/TLR10-Antibody-3C10C5-Flow-Cytometry-NBP1-70343-img0005.jpg "Flow Cytometry: TLR10 Antibody (3C10C5) [NBP1-70343] - Analysis using the Alexa Fluor (R) 647 conjugate of NBP2-27214. Detection of TLR10 on human PBMC using 10 ul (1 ug) of TLR10 antibody and 1 ug of CD19 antibody. Image using the Azide Free format of this antibody.")
![Flow Cytometry: TLR10 Antibody (3C10C5) [NBP1-70343] - Analysis using the PE conjugate of NBP2-27214. Staining of Human PBMC were probed using 10 ul (1 ug) of TLR10 antibody and 1 ug of CD19 antibody.](http://images.novusbio.com/fullsize/TLR10-Antibody-3C10C5-Flow-Cytometry-NBP1-70343-img0003.jpg)
![Flow Cytometry: TLR7 Antibody [NBP2-24767] - Intracellular staining by analysis of TLR7 in human PBMCs using this antibody at 2 ug/ml. Shaded histogrm represents cells alone; green represents rabbit IgG isotype control, and red represents the TLR7 antibody.](http://images.novusbio.com/fullsize/TLR7-Antibody-Flow-Cytometry-NBP2-24767-img0003.jpg "Flow Cytometry: TLR7 Antibody [NBP2-24767] - Intracellular staining by analysis of TLR7 in human PBMCs using this antibody at 2 ug/ml. Shaded histogrm represents cells alone; green represents rabbit IgG isotype control, and red represents the TLR7 antibody.")
![Western Blot: TLR7 Antibody [NBP2-24767] - Analysis of human TLR7 in Ramos cell lysate in the 1) absence and 2) presence of immunizing peptide using this antibody.](http://images.novusbio.com/fullsize/TLR7-Antibody-Western-Blot-NBP2-24767-img0001.jpg)
![Immunohistochemistry-Paraffin: TLR7 Antibody [NBP2-24767] - Human brain using 1:50 dilution of TLR7 antibody on a Bond Rx autostainer (Leica Biosystems). The assay involved 20 minutes of heat induced antigen retrieval (HIER) using 10mM sodium citrate buffer (pH 6.0) and endogenous peroxidase quenching with peroxide block. The sections were incubated with primary antibody for 30 minutes and Bond Polymer Refine Detection (Leica Biosystems) with DAB was used for signal development followed by counterstaining with hematoxylin. Whole slide scanning and capturing of representative images (20X) was performed using Aperio AT2 (Leica Biosystems). Punctate staining of neurons was observed. Staining was performed by Histowiz.](http://images.novusbio.com/fullsize/TLR7-Antibody-Immunohistochemistry-Paraffin-NBP2-24767-img0005.jpg)
![Immunocytochemistry/Immunofluorescence: CD90/Thy1 Antibody (AF-9) [NBP2-45230] - Conjugated version of CD90/Thy1 antibody (AF-9) [Alexa Fluor (R) 488] (NBP2-47755AF488) stained on bovine cells. Image from verified customer review.](http://images.novusbio.com/fullsize/CD90-Thy1-Antibody-AF-9-Immunocytochemistry-Immunofluorescence-NBP2-45230-img0001.jpg "Immunocytochemistry/Immunofluorescence: CD90/Thy1 Antibody (AF-9) [NBP2-45230] - Conjugated version of CD90/Thy1 antibody (AF-9) [Alexa Fluor (R) 488] (NBP2-47755AF488) stained on bovine cells. Image from verified customer review.")
![Flow Cytometry: CD4 Antibody (B486A1) [NB100-2181] - Analysis of blood T cells using CD4 mouse mAb (M2) and negative control (M1).](http://images.novusbio.com/fullsize/CD4-Antibody-B486A1-Flow-Cytometry-NB100-2181-img0004.jpg "Flow Cytometry: CD4 Antibody (B486A1) [NB100-2181] - Analysis of blood T cells using CD4 mouse mAb (M2) and negative control (M1).")
![Western Blot: CD4 Antibody (B486A1) [NB100-2181] - Analysis of human tonsil tissue using CD4 antibody at a concentration of 2 ug/ml.](http://images.novusbio.com/fullsize/CD4-Antibody-B486A1-Western-Blot-NB100-2181-img0005.jpg)
![Formalin-fixed, paraffin-embedded human tonsil stained with CD45 antibody (2B11) [NBP2-32934].](http://images.novusbio.com/fullsize/CD45-Antibody-2B11-Immunohistochemistry-Paraffin-NBP2-32934-img0002.jpg "Formalin-fixed, paraffin-embedded human tonsil stained with CD45 antibody (2B11) [NBP2-32934].")
![Formalin-fixed, paraffin-embedded human tonsil (10X) stained with CD45 antibody (2B11) [NBP2-32934].](http://images.novusbio.com/fullsize/CD45-Antibody-2B11-Immunohistochemistry-Paraffin-NBP2-32934-img0001.jpg)
![Immunocytochemistry/Immunofluorescence: CD45 Antibody (135-4C5) [NBP2-44863] - Immunofluorescence Analysis of PFA-fixed Jurkat cells labeling CD45RA with CD45 antibody (135-4C5) [NBP2-44863] followed by Goat anti-Mouse IgG-CF488 (Green). The nuclear counterstain is Red Dot.](http://images.novusbio.com/fullsize/CD45-Antibody-135-4C5-Immunocytochemistry-Immunofluorescence-NBP2-44863-img0003.jpg "Immunocytochemistry/Immunofluorescence: CD45 Antibody (135-4C5) [NBP2-44863] - Immunofluorescence Analysis of PFA-fixed Jurkat cells labeling CD45RA with CD45 antibody (135-4C5) [NBP2-44863] followed by Goat anti-Mouse IgG-CF488 (Green). The nuclear counterstain is Red Dot.")
![Immunohistochemistry-Paraffin: CD45 Antibody (135-4C5) [NBP2-44863] - Human Tonsil stained with CD45 antibody (135-4C5) [NBP2-44863].](http://images.novusbio.com/fullsize/CD45-Antibody-135-4C5-Immunohistochemistry-Paraffin-NBP2-44863-img0001.jpg)
![Flow Cytometry: CD45 Antibody (135-4C5) [NBP2-44863] - Flow cytometry analysis of lymphocyte gated PBMCs unstained (gray) or stained with CD45 antibody (135-4C5) (green).](http://images.novusbio.com/fullsize/CD45-Antibody-135-4C5-Flow-Cytometry-NBP2-44863-img0004.jpg)
![Flow Cytometry: CD45 Antibody (135-4C5) [NBP2-44863] - Flow Cytometric Analysis of PFA-fixed Jurkat cells using CD45 antibody (135-4C5) [NBP2-44863] followed by Goat anti-Mouse-IgG-CF488 (Blue); Isotype Control (Red).](http://images.novusbio.com/fullsize/CD45-Antibody-135-4C5-Flow-Cytometry-NBP2-44863-img0002.jpg)
![Western Blot: TLR2 Antibody (67N8F8) [NBP2-25245] - Analysis of human lymph node tissue using TLR2 antibody at a concentration of 1 ug/ml.](http://images.novusbio.com/fullsize/TLR2-Antibody-67N8F8-Western-Blot-NBP2-25245-img0004.jpg "Western Blot: TLR2 Antibody (67N8F8) [NBP2-25245] - Analysis of human lymph node tissue using TLR2 antibody at a concentration of 1 ug/ml.")
![Immunohistochemistry-Paraffin: TLR2 Antibody (67N8F8) [NBP2-25245] - FFPE human esophageal squamous cell carcinoma stained with TLR2 antibody at 5 ug/ml.](http://images.novusbio.com/fullsize/TLR2-Antibody-67N8F8-Immunohistochemistry-Paraffin-NBP2-25245-img0003.jpg)
![Flow (Cell Surface): TLR2 Antibody (67N8F8) [NBP2-25245] - Analysis using the FITC conjugate of NBP2-25259. Surface staining of stable HEK293/hTLR2 cells (red) and vector control cells (green) using TLR2 antibody at 5 ul/10^6 cells. Image using the Azide Free form of this antibody.](http://images.novusbio.com/fullsize/TLR2-Antibody-67N8F8-Flow-Cell-Surface-NBP2-25245-img0005.jpg)
![Western Blot: TLR2 Antibody (67N8F8) [NBP2-25245] - Analysis of (A) TLR2 partial recombinant protein, (B) transfected cell lysate, and (C) control 293T lysate using TLR2 antibody at 1 ug/ml.](http://images.novusbio.com/fullsize/TLR2-Antibody-67N8F8-Western-Blot-NBP2-25245-img0001.jpg)
![Flow Cytometry: TLR2 Antibody (67N8F8) [NBP2-25245] - (A) Surface staining of transfected TLR2 HEK293 cells (red) and mock transfected cells (green) using TLR2 antibody at 1 ug/10^6 cells. FITC-conjugated anti-mouse IgG secondary was used for this test. (B) Surface staining of PPI-negative PBMC (monocyte-gated) using TLR2 antibody (red) and isotype control antibody (green) at 1 ug/10^6 cells. PE-conjugated anti-mouse IgG secondary was used for this test.](http://images.novusbio.com/fullsize/TLR2-Antibody-67N8F8-Flow-Cytometry-NBP2-25245-img0002.jpg)
![Immunohistochemistry-Frozen: Complement C4d Antibody (12D11) [NBP2-62802] - IHC-F of human tonsil using this antibody.](http://images.novusbio.com/fullsize/Complement-C4d-Antibody-12D11-Immunohistochemistry-Frozen-NBP2-62802-img0001.jpg "Immunohistochemistry-Frozen: Complement C4d Antibody (12D11) [NBP2-62802] - IHC-F of human tonsil using this antibody.")